<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">3825</item><item key="factors"><item><item key="GSM603015"><item key="CELL LINE">bj-fib_1: BJ (CRL-2522) fibroblasts were purchased from ATCC.</item><item key="BIOSOURCEPROVIDER">ATCC</item></item></item><item><item key="GSM603043"><item key="CELL LINE">bj-fib_2: BJ (CRL-2522) fibroblasts were purchased from ATCC.</item><item key="BIOSOURCEPROVIDER">ATCC</item></item></item><item><item key="GSM603044"><item key="CELL LINE">hgps-fib_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository</item><item key="BIOSOURCEPROVIDER">Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=AG01972</item></item></item><item><item key="GSM603045"><item key="CELL LINE">hgps-fib_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository</item><item key="BIOSOURCEPROVIDER">Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=AG01972</item></item></item><item><item key="GSM603050"><item key="CELL LINE">bj-ipsc_1: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below</item><item key="BIOSOURCEPROVIDER">ATCC</item></item></item><item><item key="GSM60305"><item key="CELL LINE">bj-ipsc_2: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below</item><item key="BIOSOURCEPROVIDER">ATCC</item></item></item><item><item key="GSM603052"><item key="CELL LINE">hgps-ipsc_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below</item><item key="BIOSOURCEPROVIDER">Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=AG01972</item></item></item><item><item key="GSM603053"><item key="CELL LINE">hgps-ipsc_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below.</item><item key="BIOSOURCEPROVIDER">Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=AG01972</item></item></item><item><item key="GSM603054"><item key="CELL LINE">h9-esc_1: H9 hESCs (WiCell Research)</item><item key="BIOSOURCEPROVIDER">WiCell Research</item></item></item><item><item key="GSM603055"><item key="CELL LINE">h9-esc_2: H9 hESCs (WiCell Research)</item><item key="BIOSOURCEPROVIDER">WiCell Research</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">Hutchinson-Gilford progeria syndrome (HGPS) is a rare and fatal human premature aging disease1-5, characterized by premature...</item><item key="pubmed_id">21346760</item><item key="geo_gse_id">E-GEOD-24487</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">10</item><item key="tags"><item>atherosclerosis</item><item>hutchinson-gilford progeria syndrome</item><item>lamin a</item><item>muscle</item><item>nuclear lamina</item><item>point</item><item>protein</item><item>protein complex</item><item>syndrome</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">recapitulation-of-human-premature-aging-by-using-i</item><item key="geo_id_plat">E-GEOD-24487_A-AFFY-44</item><item key="name">Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome</item><item key="created">Sep.15, 2014</item><item key="summary">Hutchinson-Gilford progeria syndrome (HGPS) is a rare and fatal human premature aging disease1-5, characterized by premature atherosclerosis and degeneration of vascular smooth muscle cells (SMCs)6-8. HGPS is caused by a single-point mutation in the LMNA gene, resulting in the generation of progerin, a truncated mutant of lamin A. Accumulation of progerin leads to various aging-associated nuclear defects including disorganization of nuclear lamina and loss of heterochromatin9-12. Here, we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts obtained from patients with HGPS. HGPS-iPSCs show absence of progerin, and more importantly, lack the nuclear envelope and epigenetic alterations normally associated with premature aging. Upon differentiation of HGPS-iPSCs, progerin and its associated aging consequences are restored. In particular, directed differentiation of HGPS-iPSCs to SMCs leads to the appearance of premature senescent SMC phenotypes associated with vascular aging. Additionally, our studies identify DNA-dependent protein kinase catalytic subunit (DNAPKcs) as a component of the progerin-containing protein complex. The absence of nuclear DNAPKcs correlates with premature as well as physiological aging. Since progerin also accumulates during physiological aging6,12,13, our results provide an in vitro iPSC-based model with an acceleration progerin accumulation to study the pathogenesis of human premature and physiological vascular aging. Microarray gene expression profiling was done to: (1) Compare differences between WT fibroblasts and fibroblasts from patients suffering of the Hutchinson-Gilford progeria syndrome (2) Check that iPSC originating from WT and patients are in fact similar to ESC</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-24487</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-24487/samples/</item></data></biogps>
